RecallRadar

FDA Device recall Z-1622-2015

Homocysteine test system - Homocysteine Reagent. 05385415190

On 2015-05-27 the FDA classified a Class II recall of Homocysteine test system - Homocysteine Reagent. 05385415190 by Roche Diagnostics Operations, citing customers complained about under-recovery of non-Roche controls and discrepant low patient results with certain Homocysteine reagent lots. This negative bias could, in the worst c….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1622-2015
ClassificationClass II
Statusterminated
Initiated2015-03-23
Published2015-05-27
Last updated2026-09-13 11:53 UTC
CompanyRoche Diagnostics Operations
DistributionUS

Product

Homocysteine test system - Homocysteine Reagent. 05385415190; Homocysteine 100 Tests, cobas c, COBAS INTEGRA Homocysteine Enzymatic Assay is an in vitro test for the quantitative determination of total L-homocysteine in human serum and plasma on Roche/Hitachi cobas c systems.

Reason

Customers complained about under-recovery of non-Roche controls and discrepant low patient results with certain Homocysteine reagent lots. This negative bias could, in the worst case, lead to inaccurately low Homocysteine results. An elevated level of Homocysteine is considered an important risk factor in the assessment of peripheral vascular disease. Falsely low values could lead to a delay of di

Identifiers

code_info05385415190, Homocysteine 100Tests, cobas c, COBAS INTEGRA Lot number 69781101

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1622-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.